Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PROCLAIM: Pilot Study Examining Effects of Clopidogrel Compared to Placebo on Markers of Inflammation in Subjects With Metabolic Syndrome

NCT00296803 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00296803
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00296803 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PROCLAIM: Pilot Study Examining Effects of Clopidogrel Compared to Placebo on Markers of Inflammation in Subjects With Metabolic Syndrome
Lead sponsor
Sanofi
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2005
Completion date
August 31, 2006
Enrollment
216
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic syndrome x